RSV protection rises with vaccine for older people and new infants

The respiratory syncytial virus (RSV) vaccine is around 82% effective in older people, a study by the UK Health Security Agency (UKHSA) in partnership with NHS trusts has shown. The study results, published as a pre-print in June 2025, revealed that the vaccine is around 82% effective in preventing hospital admissions in patients aged 75–79 […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.367254
Primary Topic: Respiratory viral infections research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

RSV protection rises with vaccine for older people and new infants

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Respiratory viral infections research

article

RSV protection rises with vaccine for older people and new infants

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Zero hunger

Openalex Percentile: Top 73%

Respiratory viral infections research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

RSV protection rises with vaccine for older people and new infants · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS